Evidence map›Paper›PMID 30046987›Full record

ArticleInternational journal of hematology2018

The number of CD34

Yoshikazu Matsuoka, Fumiaki Nakamura, Kazuo Hatanaka, Tatsuya Fujioka, Satoshi Otani, Takafumi Kimura, Yoshihiro Fujimura, Hiroaki Asano, Yoshiaki Sonoda

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Similarities Between Stem Cell Niches in Glioblastoma and Bone Marrow: Rays of Hope for Novel Treatment Strategies.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Article
  4. Effects of VEGFR1Journal of cancer research and clinical oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yoshikazu MatsuokaDepartment of Stem Cell Biology and Regenerative Medicine, Graduate School of Medical Science, Kansai Medical University, Hirakata, Osaka, 573-1010, Japan.
Fumiaki NakamuraClinical Development and Operations, Product Development Department, Bayer Yakuhin, Ltd, Osaka, Japan.
Kazuo HatanakaDepartment of Hematology, Osaka Red Cross Hospital, Osaka, Japan.
Tatsuya FujiokaDepartment of Stem Cell Biology and Regenerative Medicine, Graduate School of Medical Science, Kansai Medical University, Hirakata, Osaka, 573-1010, Japan.
Satoshi OtaniJapanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Takafumi KimuraJapanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Yoshihiro FujimuraJapanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Hiroaki AsanoGraduate School of Nursing for Health Care Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yoshiaki SonodaDepartment of Stem Cell Biology and Regenerative Medicine, Graduate School of Medical Science, Kansai Medical University, Hirakata, Osaka, 573-1010, Japan. sonoda@hirakata.kmu.ac.jp.

Funding

Ministry of Health, Labour and Welfare 27090101
6 · The paper itself

Abstract

Umbilical cord blood transplantation (UCBT) is often associated with delayed neutrophil and platelet recovery. Engraftment failure is another major obstacle. Several factors influence these serious complications, including the numbers of total nucleated cells (TNCs) and CD34

Indexed as

AC133 AntigenAntigens, CD34BiomarkersBlood Cell CountCord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem CellsHumansImmunophenotypingQuality Assurance, Health CareAC133 AntigenAntigens, CD34BiomarkersCD34+CD133+ HSCsQuality assuranceUCBTUCB units

Identifiers

PMID30046987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.